In reality, most prostate cancers are detected through routine screening, typically with a simple blood test. Experts ...

There have been a number of recent high-profile cases of prostate cancer, and a number of well-known people have died after ...

Former Sky News presenter Dermot Murnaghan, who grew up in Northern Ireland, has announced his diagnosis with stage four ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Telix Pharmaceuticals’ Illuccix gets US FDA label expansion to add patient selection for radioligand therapy: Melbourne, Australia Wednesday, June 25, 2025, 17:00 Hrs [IST] Melb ...

We read with great interest the published results of the RADIOSA trial by Giulia Marvaso and colleagues.1 This well designed ...

Illuccix, a preparation kit for injectable Ga-68, has been approved to select patients for radioligand therapy before taxane ...

Pelvic floor therapy is often only associated with women who experience pelvic floor dysfunction after childbirth, but men ...

The second most common cancer among men is prostate cancer, affecting 1 in 8 men. Prostate cancer is treatable, in most cases, when the cancer remains localized to the prostate gland. But if the ...

(UroToday.com) The 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting held in New Orleans, LA, was host to an Oncology Discovery and Translational session. Dr. Huipan Liu ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...